Webinars
All our webinars include at least one speaker that is a member of ERN GENTURIS. The target audience for the webinars consists of clinicians, genetic counsellors, clinical scientists and other genetics health professionals. The webinars last approximately 20-30 minutes, and viewers have the opportunity to send questions on the subject area which will be addressed in a question & answer session afterwards. Webinars are usually held on Wednesday afternoons.
Register for the upcoming webinars:
Date |
Time |
Speaker |
Title |
Registration* |
05-10-2022 | 16:00-17:00 CEST | Maurizio Genuardi | Breaking down the process of genetic variant classification | pending |
26-10-2022 | 16:00-17:00 CEST | Janez Žgajnar | Prophylactic mastectomies – the surgeon's perspective | pending |
09-11-2022 | 16:00-17:00 CET | Angelique Flöter Rådestad | Hereditary breast- and ovarian cancer, aspects on risk reducing measures and hormonal replacement – the gyne-oncologist's perspective | pending |
23-11-2022 | 16:00-17:00 CET | Ann Nordgren & Svetlana Bajalica Lagercrantz | Childhood cancer and genetic tumour risk syndromes – the geneticist's perspective | pending |
06-12-2022 | 16:00-17:00 CET | Chella van der Post | Hereditary gastrointestinal cancer – the pathologist's perspective | pending |
* Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.
View previous webinars:
General
Neurofibromatosis
Date |
Speaker |
Title |
View** |
27-01-2022 | Sirkku Peltonen & Pierre Wolkenstein | Cutaneous neurofibromas | view |
07-12-2021 | Eric Legius | Legius syndrome and its link with Neurofibromatosis type 1 | view |
10-11-2021 | Rianne Oostenbrink | NF1 from the pediatric perspective | view |
28-10-2020 | Gareth Evans | Neurocutaneous tumour syndromes | view |
Lynch and polyposis
Date |
Speaker |
Title |
View** |
13-10-2021 | Iosune Baraibar | Update in therapeutic options for Lynch-associated colorectal cancer patients | view |
13-01-2021 | Stefan Aretz | Gastrointestinal polyposis syndromes | view |
30-09-2020 | Elke Holinski-Feder | HNPCC related tumour risk syndromes – pathomechanisms and clinical implications | view |
Hereditary breast and ovarian cancer (HBOC)
Date |
Speaker |
Title |
View** |
22-06-2022 | Joanne de Hullu | Prevention of ovarian cancer | view |
23-02-2022 | Marc Tischkowitz | Polygenic Risk Scores in breast and ovarian cancer risk prediction – ready for the clinic? | view |
10-02-2021 | Judith Balmaña | Germline mutations as a therapeutic target in breast cancer | view |
20-05-2020 | Marc Tischkowitz |
Hereditary Breast and Ovarian Cancer - BRCA1, BRCA2 and the basics |
view |
Other rare genturis
Date |
Speaker |
Title |
View** |
24-05-2022 | Fátima Carneiro | Pathology of CDH1-related diffuse gastric cancer | view |
09-03-2022 | Karin Wadt | Genetic predisposition to melanoma | view |
21-10-2021 | Jolanda Schieving | PTEN hamartoma tumour syndrome in childhood | view |
26-05-2021 | Chrystelle Colas | Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome | view |
11-05-2021 | Tanya Bisseling | A personal history about hereditary diffuse gastric cancer | view |
31-03-2021 | Yvonne Brandberg | Psychological aspects on the TP53 related cancer syndromes | view |
17-03-2021 | Eamonn Maher | Von Hippel-Lindau disease: from clinic to gene and back | view |
09-12-2020 | Nicoline Hoogerbrugge | Recognising PTEN hamartoma tumour syndrome for early cancer detection | view |
25-11-2020 | Carla Oliveira | Hereditary Gastric Cancer | view |
11-11-2020 | Evelin Schröck | Pheochromocytoma/ paraganglioma – benefit of combined germline and tumour testing for PPGL patients | view |
14-10-2020 | Thierry Frebourg | Li-Fraumeni and heritable TP53-related cancer syndromes | view |
** A recording of each webinar will be made available within a week after broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and internet connection.